Clinical trials have focused on lipid-lowering medications'
effects on subclinical cardiovascular disease as well as the role
of hormone therapy, diet and vitamin supplements on heart disease,
cancer and osteoporosis in postmenopausal women.
Jean Wactawski-Wende, PhD, principal investigator of UB’s
Women’s Health Initiative (WHI) Center, discusses the
significance of the WHI, one of the longest and most comprehensive
studies ever done on postmenopausal women.